Petmed Express IncPETS
What Petmed Express Inc does.
PetMed Express, Inc. and subsidiaries, d/b/a PetMeds®, and as parent company of PetCareRx®, is a pioneer in pet healthcare, building a consumer-first digital platform in 1996 that transformed the way customers fulfill pet medications. Thirty years later, as a leading nationwide direct-to-consumer pet health and wellness retailer, the Company markets and sells directly to consumers through its websites (Petmeds.com and PetCareRx.com), customer contact centers, and mobile applications (iOS and Android). The Company provides access to top branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter (OTC) health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and personalized AutoShip capabilities. Our digital platform offers pet healthcare solutions for a broad range of chronic conditions, including those related to allergies, arthritis, anxiety, kidneys, hyperthyroidism, and others for cats, dogs, and horses. We also offer access to a range of non-prescription health and wellness products and Rx food, non-Rx food, and treats. PetMeds and PetCareRx receive the pet’s order through our websites and mobile applications and connect to the customer's licensed veterinarian for prescription approval. Through our content website, pethealthmd.com, consumers can access educational articles for any health-related questions regarding their pets. The Company offers consumers an attractive alternative for obtaining pet medications, foods, and supplies in terms of convenience, price, speed of delivery, and valued customer service. For 30 years, PetMeds has been a trusted partner in pet health, delivering expert-backed products and pharmacy care to families.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | $303.6M | $272.3M | $247.6M | $274.1M | $227.0M | $179.0M |
| Net income | $23.9M | $18.7M | $5.1M | -$7.5M | -$6.3M | -$57.3M |
| Free cash flow | $37.6M | $16.7M | $22.5M | -$194,000 | -$395,000 | -$33.0M |
More on PETS.
- Petmed Express Inc summary
- Petmed Express Inc financial statements
- Petmed Express Inc key metrics
- Petmed Express Inc health scores and style box
- Petmed Express Inc earnings
- Petmed Express Inc dividends
- Petmed Express Inc valuation
- Petmed Express Inc ownership and insiders
- Petmed Express Inc peers
Figures from Petmed Express Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.